Fingerprint
Dive into the research topics of 'Phase II trial of PS-341 in patients with renal cell cancer: A University of Chicago phase II consortium study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of PS-341 in patients with renal cell cancer: A University of Chicago phase II consortium study
Nancy B. Davis, David A. Taber, Rafat H. Ansari, Christopher W. Ryan, Christopher George, Everett E. Vokes, Nicholas J. Vogelzang, Walter M. Stadler
Research output: Contribution to journal › Article › peer-review
140
Scopus
citations